physIQ Partners with Janssen Multi-Year Digital Health Deal
Similar Posts
Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
TRUDHESA Is the First and Only Therapeutic to Use POD technology to Deliver Dihydroergotamine Mesylate (DHE) to the Vascular-Rich…
NowRx Launches $73 Million Series C Round on Equity Crowdfunding Platform SeedInvest; Funds Will be Used to Expand Same Day Delivery of Prescriptions and Telehealth Services
Digital health platform’s last equity fundraising round was oversubscribed and raised $20 Million; NowRx has since expanded into additional…
